MannKind MNKD
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$4.66M (5 inflow days, 15 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 27.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 8.89% to 8.15% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +1,002,678 | 0.6% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +998,435 | 4.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +786,236 | 10.2% |
| Voya Investment Management LLC | Mutual Fund | 2026/Q3 | +524,726 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +438,827 | 1.4% |
| Rubric Capital Management LP | Hedge Fund | 2026/Q3 | +14,379,587 | 5.6% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +6,000,000 | 1.9% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +4,561,628 | 2.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,532,225 | 10.0% |
| Braidwell LP | Hedge Fund | 2026/Q3 | +3,458,429 | 1.1% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +3,316,723 | 1.2% |
| J. Goldman & Co., L.P. | Hedge Fund | 2026/Q3 | +816,589 | 0.3% |
| Frazier Life Sciences Management, LP | VC/PE Fund | 2026/Q3 | +700,000 | 2.1% |
| 180 Wealth Advisors, LLC | Family Office/Trust | 2026/Q3 | +667,648 | 1.5% |
| TSP Capital Management Group, LLC | Mutual Fund | 2026/Q3 | +628,700 | 1.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 24 Sep 2026 | Steven Binder | Independent Director | Automatic Disposition | -39,051 | $3.29 | 546,758 |
| 9 Sep 2026 | Steven Binder | Independent Director | Automatic Disposition | -33,558 | $3.81 | 585,809 |
| 6 Aug 2026 | Steven Binder | Independent Director | Automatic Disposition | -39,051 | $4.06 | 619,367 |
| 16 Jul 2026 | David Thomson | General Counsel | Automatic Disposition | -24,109 | $4.05 | 620,804 |
| 16 Jul 2026 | Steven Binder | Independent Director | Derivative Exercise and Sale | -76,880 | $4.09 | 658,418 |
| 14 Jul 2026 | David Thomson | General Counsel | Sale to Issuer | -4,636 | $4.09 | 620,804 |
| 14 Jul 2026 | David Thomson | General Counsel | Derivative Exercise and Sale | -93,790 | $4.09 | 620,804 |
| 14 Jul 2026 | Stuart Tross | Chief People & Workplace Officer | Derivative Exercise and Sale | -65,808 | $4.09 | 881,392 |
| 14 Jul 2026 | Stuart Tross | Chief People & Workplace Officer | Derivative Exercise and Retained | +27,982 | – | 881,392 |
| 14 Jul 2026 | Michael Castagna | Chief Executive Officer | Sale to Issuer | -12,940 | $4.09 | 2,433,779 |
| 14 Jul 2026 | Michael Castagna | Chief Executive Officer | Derivative Exercise and Sale | -350,260 | $4.09 | 2,433,779 |
| 14 Jul 2026 | Steven Binder | Independent Director | Derivative Exercise and Retained | +16,910 | – | 658,418 |
| 14 Jul 2026 | Christopher Prentiss | Chief Financial Officer | Sale to Issuer | -22,247 | $4.09 | 95,851 |
| 14 Jul 2026 | Dominic Marasco | President of Endocrine Business Unit | Sale to Issuer | -3,623 | $4.09 | 46,773 |
| 14 Jul 2026 | Sanjay Singh | Executive Vice President of Technical Operations | Derivative Exercise and Sale | -46,795 | $4.09 | 253,404 |
| 14 Jul 2026 | Sanjay Singh | Executive Vice President of Technical Operations | Derivative Exercise and Retained | +23,755 | – | 253,404 |
| 19 May 2026 | Ronald Consiglio | Independent Director | Other Acquisition | +10,000 | $2.95 | 132,342 |
| 19 May 2026 | Ronald Consiglio | Independent Director | Other Derivative Acquisition | +99,337 | – | 16,556 |
| 19 May 2026 | Christine Ann Mundkur | Independent Director | Other Derivative Acquisition | +82,781 | – | 82,781 |
| 19 May 2026 | Michael Friedman | Independent Director | Other Derivative Acquisition | +82,781 | – | 82,781 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 26,220,516 | 8.2% | 10.3 |
| 15 Oct 2026 | 25,478,417 | 7.9% | 5.1 |
| 30 Sep 2026 | 26,157,578 | 8.1% | 4.4 |
| 15 Sep 2026 | 29,398,550 | 9.1% | 9.1 |
| 31 Aug 2026 | 26,554,857 | 8.3% | 8.5 |
| 14 Aug 2026 | 28,582,134 | 8.9% | 5.6 |
No comments yet — be the first to weigh in on MNKD.
Sign in to join the discussion.